Find Academic Supervisors

Francesca StradoliniView profile

Lecturer

• Bioelectronics
• IoT for Medical Monitoring
• Anesthesia Delivery Systems
• +3 more

Francesca Stradolini is a Lecturer at École Polytechnique Fédérale de Lausanne (EPFL), affiliated with the Electrical Engineering Doctoral School (EDEE). She holds a PhD in Electrical Engineering from EPFL (2018), with prior education in Bio Engineering and Neuroscience from the University of Genoa (2012, 2015). Her current work focuses on R&D engineering for medical devices, emphasizing system lifecycle management, human factors engineering, and compliance with CE/FDA regulations. As an invited guest, she contributes to usability engineering education and interdisciplinary research at EPFL. PhD: IoT Bio-Electronic Multi-Panel Device for On-line Monitoring of Anaesthesia Delivery (EPFL, 2018) MSc: Bio Engineering (University of Genoa, 2015) BSc: Bio Engineering (University of Genoa, 2012) Her research spans bioelectronics, IoT-enabled medical monitoring, and electrochemical sensor development for clinical applications. Key areas include anesthesia delivery systems, wearable diagnostics, implantable devices, and human factors engineering. Her work integrates fluidic systems, noble metal nanostructures, and open-source hardware (e.g., Raspberry Pi) to address challenges in traceability, fouling mitigation, and pharmacokinetic modeling. Scientific recognition includes the Ville de Lausanne Award (2019) , EPFL Outstanding PhD Thesis Distinction (2018) , and a Best Paper Award at MOBIHEALTH (2016) . She has published extensively in journals like IEEE TBIOCAS, Sensors and Actuators B, and IEEE Sensors Journal, with collaborative studies on propofol monitoring, carbon nanoallotrope drug detection, and implantable sensor validation. Her technical expertise includes managing medical device development lifecycles, designing IoT architectures for intensive care, and optimizing electrochemical sensors for stability in undiluted biological fluids. She has contributed to conferences such as IEEE BioCAS, ISCAS, and MOBIHEALTH, focusing on translational studies in personalized medicine and 3D-printed medical systems.

Daniel FinleyView profile

Professor

• Ubiquitin-Proteasome Pathway
• Proteostasis
• Protein Degradation
• +7 more

Daniel Finley is a Professor of Cell Biology at Harvard Medical School (HMS), leading the Finley Lab focused on the ubiquitin-proteasome pathway and related regulatory mechanisms. He holds academic appointments within the Department of Cell Biology and sits on the Scientific Advisory Boards of Proteostasis and X-Chem Pharmaceuticals. His research investigates proteasome function, ubiquitin-like proteins, and proteostasis roles in diseases like Alzheimer’s and ALS. Dr. Finley earned his undergraduate degree in biochemistry from Harvard University and a Ph.D. in molecular biology from MIT. After postdoctoral training at MIT, he joined HMS in 1988. His lab explores topics including erythroid proteome remodeling, mitochondrial dysfunction, and neurodegenerative disease mechanisms. Key research areas include: (1) Ubiquitin-proteasome pathway regulation, (2) Proteasome structure/function, (3) Nonproteolytic roles of ubiquitination, and (4) Pathophysiological roles of proteostasis defects in diseases. His work bridges basic cell biology with translational medicine, particularly in neurodegeneration and anemia. Finley has secured NIH funding for projects like 'Regulation of Proteasome Activity' (R35GM145246) and 'Erythrocyte maturation through global proteome remodeling' (R01HL153970). Collaborations with industry and academic partners extend his impact in drug discovery and proteasome-targeted therapies. His lab’s contributions include defining ubiquitin chain editing mechanisms, identifying USP14’s role in mitophagy, and elucidating proteostasis defects in Alzheimer's models. Research tools developed include advanced cryo-EM analyses of proteasomal structures and functional assays for ubiquitin system enzymes.

Michael McAlpineView profile

Professor

• 3D Printing
• Nanotechnology
• Biomedical Engineering
• +4 more

Michael McAlpine is a Professor in the Mechanical Engineering department at the University of Minnesota . He also holds affiliations with the Biomedical Engineering and Electrical and Computer Engineering departments. His research focuses on 3D printing functional materials & devices , Nanoscale inks , Biomedical devices , Bioelectronics , and Flexible Microsystems . Research Interests : 3D Printing, Biomedical Engineering, Nanotechnology, Flexible Electronics, Microfluidics Labs : ME 361/363 Contact : mcalpine@umn.edu , (612) 626-3303, ME 117 Recent Research Trends include 3D Printed Biomedical Devices , Flexible Electronics , and Bioprinting Applications . His work spans from Spinal Organoid Formation to Programmable Drug Release Capsules . Scientific Award : Circulation Research 2020 Best Manuscript Award

Thibault MayorView profile

Professor

• Protein Homeostasis
• Ubiquitin Proteasome System
• Neurodegenerative Diseases
• +7 more

Thibault Mayor is a Professor in the Department of Biochemistry and Molecular Biology and the Michael Smith Laboratories at the University of British Columbia (Vancouver). His research focuses on understanding how cells manage misfolded proteins, with implications for neurodegenerative diseases like Parkinson's and Alzheimer's. He holds academic affiliations with the Centre for High-Throughput Biology (CHiBi) and has been recognized with awards including the UBC Killam Teaching Award (2020). Education: BSc, University of Geneva, Switzerland (1997) PhD, University of Geneva & Max Planck Institute of Biochemistry, Germany (2001) Postdoctoral Fellow, California Institute of Technology (2002) Research Interests: Mayor's lab investigates protein homeostasis, ubiquitin-proteasome system dynamics, and the molecular mechanisms underlying protein aggregation in aging and disease. Projects include proteomic approaches to identify aggregation-prone proteins and develop microbial cell factories for protein production. Grants & Awards: CIHR Project Grant ($730K, 2018) Michael Smith Foundation Career Award (2012) UBC Killam Teaching Award (2020) Labs & Collaborations: The Mayor Lab is part of the Michael Smith Laboratories and collaborates with computational biologists like Jörg Gsponer. They maintain active partnerships in proteomics and systems biology, contributing to initiatives like the BC Proteomics Network.

Andre DeHonView profile

Professor

• Reconfigurable Computing
• FPGA Architecture
• Interconnect Design
• +6 more

André DeHon is the Oliver C. Boileau Jr. and Nan Eleze Boileau Professor of Electrical Engineering at the University of Pennsylvania, with affiliations in the Electrical and Systems Engineering (ESE) and Computer and Information Science (CIS) departments. He founded the Penn Computer Engineering (CMPE) program and directs the DARPA-sponsored CyberSavvy Security Center. His research spans reconfigurable computing, FPGA architecture, interconnect design, hardware security, and energy efficiency, with a focus on adapting to fabrication imperfections and runtime variability. His work explores programmable substrates (e.g., CMOS VLSI, molecular electronics) and algorithmic mappings to create resilient, efficient systems. Current projects include runtime feedback mechanisms (REFINE), partial reconfiguration (ExHiPR), and security frameworks like SCALPEL and μSCOPE. Recent publications highlight advancements in FPGA compilation (PLD, HiPR), security (SCALPEL, μSCOPE), and interconnect optimization (Asymmetry in NoC). These studies intersect computer architecture, security, and embedded systems. Scientific awards and recognitions: 2023 IEEE Fellow 2020 IEEE Mary Kenneth Keller Teaching Award 2018 ACM Fellow TCFPGA Hall of Fame (2019) Best Paper at ICFPT 2015 Academic leadership: He chairs the ACM/SIGDA Technical Committee on FPGAs and Reconfigurable Computing, previously held faculty roles at Caltech (1999–2006), and was a postdoc at UC Berkeley (1996–1999). Education includes MIT SB (1990), SM (1993), and PhD (1996) in Electrical Engineering and Computer Science.

Steven G. ClarkeView profile

Professor

• Biochemistry
• Systems Biology
• Biological Regulation
• +8 more

Dr. Steven G. Clarke is a Distinguished Professor at UCLA Department of Chemistry & Biochemistry and director of research at the Molecular Biology Institute . His work bridges protein chemistry , methylation biology , and aging research through studies of spontaneous protein damage and its repair mechanisms. Education: BA in Chemistry and Zoology, Pomona College (magna cum laude, Phi Beta Kappa) PhD in Biochemistry and Molecular Biology, Harvard University (NSF Fellow) Postdoctoral Fellowship at UC Berkeley (Miller Fellow) Dr. Clarke's research focuses on protein isoaspartyl repair via PCMT1/PIMT enzymes , ribosomal protein methylation in Saccharomyces cerevisiae , and PRMT family characterization including PRMT7 and PRMT9. His lab combines biochemical assays , genetic models , and structural analysis to investigate aging mechanisms and disease implications. Recent publications highlight: COQ5 structure-function analysis in coenzyme Q biosynthesis PCMTD1 ubiquitin ligase interactions PRMT7 substrate specificity in histone H2B Protein isoaspartyl impacts on T cell function in lupus Novel PRMT inhibitors for cancer therapy Methionine addiction in osteosarcoma malignancy Major scientific awards: American Chemical Society Ralph F. Hirschmann Award in Peptide Chemistry NIH MERIT Award Ellison Medical Foundation Senior Scholar Award William C. Rose Award, ASBMB UCLA Distinguished Teaching Award (Eby Award winner) Current lab members include PhD candidates Eric Pang (UCSB) and Sining "Cindy" Wang (UCLA), while undergraduates Celeste Medina-Seymoure , Elizabeth Oroudjeva , Olivia Pacheco , and Jasmine Winter contribute to ongoing proteostasis studies. Collaborations with Profs. Jose Rodriguez and Catherine Clarke demonstrate interdisciplinary research approaches.

Ulf HanefeldView profile

Professor

• Biocatalysis
• Enzyme Engineering
• Green Chemistry
• +7 more

Ulf Hanefeld is a Full Professor and Section Leader in the Department of Biotechnology at the Faculty of Applied Sciences , Delft University of Technology (TU Delft) , where he leads the Biocatalysis research section. His work integrates chemistry and biology to develop sustainable synthetic methodologies using enzymes. PhD from Georg-August-Universität zu Göttingen (1993) Postdoctoral experience at Imperial College London, University of Cambridge, and TU Delft Recipient of a Royal Netherlands Academy of Arts and Sciences (KNAW) fellowship His research interests center on biocatalysis , particularly enzymes that enable difficult chemical transformations such as C–C bond formation , enantioselective hydration , and ozonolysis . He focuses on enzyme discovery, engineering, immobilization, and application in flow chemistry to achieve sustainable and efficient synthesis. His work spans from fundamental enzyme mechanism studies to industrial applications in green chemistry . The publication trends reveal a consistent focus on enzyme immobilization , flow reactor systems , and chemo-enzymatic cascades . His recent work emphasizes the use of hydroxynitrile lyases , aldolases , and methyltransferases for the synthesis of chiral intermediates under environmentally benign conditions. The integration of biocatalysis with continuous manufacturing highlights a strong commitment to industrial applicability and process sustainability. Scientific contributions and recognition : Active contributor to high-impact journals in chemistry and biotechnology Coordinated research in the CassaFLOW project (international academic-industrial collaboration) Author of influential reviews, e.g., in Chemical Society Reviews (2022) Teaching and supervision : He teaches Catalysis (Bachelor) and Advanced Biocatalysis (Master), and supervises numerous Master’s theses (MEP) and Bachelor’s projects (BEP) . Students in his group are actively involved in research and often become co-authors on scientific papers. Projects center on green chemistry, enzyme engineering, and spectroscopic analysis of biochemical systems. Laboratory and research environment : The Ulf Hanefeld Group operates within the Biocatalysis section, a multidisciplinary environment fostering collaboration on enzyme discovery, immobilization, and cascade reactions. The group emphasizes practical innovation, with strong links to industry and international research networks.

• Advanced Electronics Cooling
• Phase-Change Transport Phenomena
• Additive Manufacturing
• +7 more

Justin A. Weibel is a Professor of Mechanical Engineering at Purdue University, affiliated with the School of Mechanical Engineering. He directs the Cooling Technologies Research Center (CTRC), a National Science Foundation Industry/University Cooperative Research Center. His research focuses on advanced electronics cooling, phase-change transport, additive manufacturing for thermal components, and machine-learning-driven design optimization. He has led projects funded by DARPA, ONR, ARPA-E, and industry partners, advancing cooling solutions for high-power electronics and energy systems. Research interests span thermal management, heat transfer, micro/nano-scale engineering, and sustainable energy. Key contributions include topology optimization for heat sinks, two-phase flow modeling, and embedded cooling systems for electric motors. His work integrates computational methods with experimental validation. Grants & Programs: DARPA TGP/ICECool, ONR NEPTUNE, ARPA-E ASCEND/COOLERCHIPS, SRC CHIRP Labs: Cooling Technologies Research Center (CTRC) Future Work: Expanding additive manufacturing applications, improving thermal efficiency in electrified transport, and advancing AI-driven thermal system design. Awards: Fellow of ASME (2023) Outstanding Faculty Mentor (2022) Multiple best paper awards from IEEE ITherm, ASME, and SEMI-THERM conferences

Patricia ChampionView profile

Professor

• Molecular Genetics
• Mycobacterial Pathogenesis
• Bacterial Genetics
• +7 more

Patricia Champion is a Professor in the Department of Biological Sciences at the University of Notre Dame, where she holds the title of Notre Dame Collegiate Professor. Her research is centered on the molecular mechanisms of mycobacterial pathogenesis, with a focus on protein transport and virulence. She is affiliated with the Eck Institute for Global Health and the Center for Rare and Neglected Diseases. PhD in Molecular Biology, Princeton University (2003) B.S. in Biological Sciences, Carnegie Mellon University (1998) Her research interests lie in understanding how pathogenic mycobacteria, including Mycobacterium tuberculosis and M. marinum , cause disease through targeted protein secretion, particularly via the Type VII (ESX-1) secretion system. She investigates how secreted proteins function as effectors and regulate gene expression, and how post-translational modifications like acetylation influence virulence. Her lab employs an interdisciplinary approach combining genetics, molecular biology, proteomics, and transcriptomics. The recent publications highlight a strong focus on ESX-1-mediated secretion, identification of novel substrates, regulatory mechanisms (e.g., WhiB6, EspM), and post-translational modifications. The work spans fundamental bacterial physiology to host-pathogen interactions, contributing to the broader goal of identifying targets for anti-virulence therapeutics against tuberculosis. Her scientific recognition includes being named a Notre Dame Collegiate Professor, a distinguished honor reflecting her scholarly excellence. Dr. Champion leads an active research laboratory committed to fostering an inclusive and respectful environment, emphasizing core values such as integrity, teamwork, and excellence. Her lab's work is supported by ongoing research grants, though specific funding sources are not detailed in the text. The Champion Lab operates within the Department of Biological Sciences and collaborates with key institutes at Notre Dame focused on global and neglected diseases.

Weiqiang ChenView profile

Professor

• Lab-on-a-Chip
• Organ-on-Chip
• Biomaterials
• +7 more

Weiqiang Chen is a Professor of Mechanical and Biomedical Engineering at New York University's Tandon School of Engineering and Director of Research and PhD Programs. He holds a joint appointment at NYU Langone's Perlmutter Cancer Center as a Faculty Member of the Tumor Immunology Research Program. B.S. in Physics (Nanjing University, 2005) M.S. in Electrical Engineering (Shanghai Jiao Tong University, 2008) M.S. in Electrical and Computer Engineering (Purdue University, 2009) Ph.D. in Mechanical Engineering (University of Michigan, 2014) His research focuses on Lab-on-a-Chip , Organ-on-Chip systems, Biomaterials , and Mechanobiology , with applications in cancer biology, stem cell engineering, and immune monitoring. He pioneers microfabrication technologies for real-time observation of cellular interactions, including CAR T-cell immunotherapy efficacy and tumor microenvironment dynamics. Recent grants include NSF funding for leukemia bone marrow niche modeling, NIH Trailblazer Awards for glioblastoma immunotherapy research, and collaborations with the Arthritis Foundation for synovium-on-chip rheumatoid arthritis studies. His work has been supported by over $2M in federal and institutional research funding. National Science Foundation (NSF) grants for leukemia-on-chip and glioblastoma modeling National Institutes of Health (NIH) awards for immunotherapy research American Heart Association fellowships and institutional training programs Chen's scientific awards include the American Heart Association Fellow distinction, multiple Young Investigator Awards from Lab on a Chip and Biomedical Engineering Society, and recognition for his dissertation on nanotopography in stem cell differentiation. He leads the Applied Micro-Bioengineering Laboratory (AMBL) , which develops microphysiological systems for drug testing and personalized medicine. His team has created the first immunocompetent leukemia-on-a-chip for CAR T-cell therapy screening and glioblastoma models that enable patient-specific immunotherapy validation.

Jiwoong ParkView profile

Professor

• Nanomaterials
• Atomically-thin materials
• Materials Chemistry
• +7 more

Jiwoong Park is Professor of Chemistry and Chair of the Department of Chemistry at the University of Chicago, and simultaneously Professor of Molecular Engineering in the Pritzker School of Molecular Engineering. His interdisciplinary research group, the Park Group, is jointly affiliated with the James Franck Institute and the Materials Research Science and Engineering Center (MRSEC) at UChicago, and operates from the Gordon Center for Integrative Science. Education & Training Ph.D., University of California, Berkeley (2003) B.S., Seoul National University (1996) Junior Fellow, Rowland Institute, Harvard University (2003–2006) Assistant → Associate Professor, Department of Chemistry and Chemical Biology, Cornell University (2006–2016) Research Interests Park’s research centers on the science and technology of precisely engineered nanomaterials, particularly atomically-thin two-dimensional (2D) crystals and van der Waals solids. Spanning chemistry, physics, materials science and electrical engineering, his group develops novel synthetic, imaging and characterization techniques to uncover new physical phenomena and translate them into scalable device technologies. Key thrusts include growth of wafer-scale molecular crystals, optical and transport spectroscopy of 2D semiconductors, mechanical behavior of polycrystalline nanomembranes, and integration of these materials into photonic, electronic and energy-harvesting devices. Scientific Awards Elected Fellow of the American Physical Society (2022) – “for the development of synthetic, imaging, and characterization techniques of atomically thin materials and the discovery of novel properties of van der Waals solids.” Clarivate Highly Cited Researcher (2023) – recognition for multiple papers ranking in the global top 1% by citations in Materials Science and Chemistry. Group & Collaborations The Park Group is an interdisciplinary team of postdocs, graduate researchers and undergraduates housed in the Gordon Center for Integrative Science. The group actively collaborates with colleagues across the Department of Chemistry, Department of Physics, and the Pritzker School of Molecular Engineering, leveraging shared facilities at the James Franck Institute and MRSEC to push the frontiers of 2D material science.

Andrew YonelinasView profile

Professor

• Human Memory
• Cognitive Neuroscience
• Memory Processes
• +5 more

Andrew Yonelinas is a Professor in the Department of Psychology at the University of California, Davis, where he directs the Human Memory Lab. He holds additional leadership roles as Associate Director of the Center for Mind and Brain and is an affiliated faculty member with the UC Davis Center for Neuroscience. His research bridges cognitive psychology and neuroscience to investigate fundamental memory mechanisms and their neural substrates. His educational background includes a Ph.D. in Experimental Psychology from McMaster University (1995) and a B.S. in Cognitive Science from the University of Toronto (1990). These foundational studies established his expertise in experimental methodologies and cognitive theory. Yonelinas specializes in dual-process models of memory, distinguishing between recollection (detailed contextual retrieval) and familiarity (vague recognition). His lab employs process dissociation, remember/know procedures, and ROC modeling alongside neuroimaging (fMRI, ERP) and clinical studies with amnesic and Alzheimer's patients. Recent work expands into auditory working memory, multisensory integration, and the impact of mental illness on cognitive processes, revealing hippocampal roles across memory systems. His research consistently addresses how memory fails in clinical conditions while developing unified theoretical frameworks. Analysis of his 2024-2025 publications shows a strong focus on memory mechanisms across sensory modalities, with increasing emphasis on clinical applications. Key trends include hippocampal contributions to visual/auditory working memory, EEG-based biomarkers for mental illness, and the interplay between schema knowledge and memory distortion in aging populations. His work demonstrates methodological innovation through model-based EEG phenotyping and multisite clinical collaborations. His scientific recognition includes: American Psychological Society’s Shahin Hashtroudi Memorial Award University of California Chancellor’s Fellow Award European Brain and Behavior Society International Lecture Award Yonelinas actively shapes his field through editorial roles at top journals including Proceedings of the National Academy of Sciences and Journal of Experimental Psychology, while serving as a grant reviewer for NIH, NSF, and international funding bodies. His Human Memory Lab trains next-generation researchers in memory theory and methodology, with recent projects examining stress effects on memory precision and neural mechanisms of action slips. The Human Memory Lab operates within UC Davis's neuroscience ecosystem, collaborating closely with the Center for Mind and Brain on projects involving clinical populations and neuroimaging. Current initiatives include the CNTRACS Consortium for EEG standardization in mental illness and investigations into how stress modulates memory binding through hippocampal mechanisms.

• Catalysis
• Nanotechnology
• Environmental Chemistry
• +3 more

Dr. Suresh Bhargava is a Distinguished Professor and Director of AcSIR at RMIT University's Research & Innovation department. He has led interdisciplinary research in materials science, catalysis, and environmental engineering for over three decades, with a focus on strengthening Indo-Australian scientific collaboration. His work bridges academia and industry, addressing challenges in pollution control, nanotechnology, and cancer treatment. Research & Leadership: Established RMIT's Centre for Advanced Materials and Industrial Chemistry (CAMIC), pioneering translational research with industry applications. Supervised 70+ PhD students (100% employment rate), many now leading roles at global institutions. Holds distinguished professorships across six countries and advises governments and Fortune 500 firms on environmental and industrial issues. Awards & Recognition: Recipient of Australia's Member of the Order of Australia (2022), India's P.C. Ray Chair (2014), and the Khwarizmi International Award (2016). His work on mercury pollution control and gold-based anticancer drugs has garnered global acclaim, with over 800 publications (26,000+ citations, h-index 86). Key Contributions: Architect of the Australia-India Strategic Research Fund and the RMIT-AcSIR Joint Research Program. Innovated eco-friendly graphene production from eucalyptus bark and patented anti-cancer gold compounds. Advises on sustainable mineral processing, hydrogen energy, and CO₂ valorization. Industry Engagement: Consulted for Rio Tinto, BHP Billiton, and CSIRO on resource efficiency, pollution mitigation, and nanotechnology applications. His research has created jobs and driven innovation in Australia and Asia-Pacific.

James C. GumbartView profile

Adjunct Professor

• Computational Biochemistry and Biophysics
• Membrane proteins
• Free-energy calculations
• +7 more

James C. Gumbart is an Adjunct Professor in the School of Physics at Georgia Institute of Technology, with additional affiliation to the School of Chemistry and the Institute for Bioengineering and Bioscience . His research leverages molecular dynamics simulations to decode the atomic-level mechanisms of bacterial proteins and cellular structures. B.S., Physics and Mathematics, Western Illinois University, 2003 Ph.D., Physics, University of Illinois at Urbana Champaign, 2009 Dr. Gumbart's work bridges computational biophysics and biochemistry to understand: Mechanisms of bacterial membrane protein insertion and nutrient import Structural dynamics of cell wall mechanics SARS-CoV-2 spike protein interactions with ACE2 Free-energy calculations for protein-ligand binding Applications of machine learning in biomolecular simulations His publications reflect trends in membrane protein biophysics , viral dynamics , and computational drug design , with a strong emphasis on interdisciplinary techniques. Awards include multiple fellowships and grants from NSF , DOE , and NIAID . He has mentored numerous PhD students, including Zijian Zhang , David Ryoo , and Andrew Pang , whose work has advanced understanding of bacterial systems and viral proteins. The Gumbart Lab integrates high-powered supercomputing and advanced software to model biomolecular processes, fostering collaborations with institutions like the National Institutes of Health and Argonne National Laboratory .

Wei-Jen TangView profile

Professor

• Structural Biology
• Biochemistry
• Molecular Biology
• +4 more

Wei-Jen Tang is a Professor at the University of Chicago, affiliated with the Ben May Department of Cancer Research. His work integrates structural biology and biochemistry to study protein interactions critical to human health, particularly in Alzheimer's disease, diabetes, and bacterial pathogenesis. Education: B.S. in Zoology, National Taiwan University; Ph.D. in Biological Sciences, University of Texas, Austin; Postdoctoral training in Virology and Pharmacology at University of Texas Southwestern. His research focuses on: Amyloid Peptide-Degrading Proteases: IDE and PreP for Alzheimer's and diabetes. Chemokines: CCL5 and CCL3 in inflammation and HIV. Bacterial Toxins: Edema factor in anthrax and bio-defense. Recent publications highlight structural insights into IDE, PreP, and anthrax toxins, with keywords spanning Structural Biology , Biochemistry , and Therapeutics . Funding includes NIH and American Heart Association grants. Awards include AHA Established Investigator and Cancer Research Foundation Young Investigator. Lab updates note new members and a 2025 publication on PreP.